1. Home
  2. VKTX vs SMTC Comparison

VKTX vs SMTC Comparison

Compare VKTX & SMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • SMTC
  • Stock Information
  • Founded
  • VKTX 2012
  • SMTC 1960
  • Country
  • VKTX United States
  • SMTC United States
  • Employees
  • VKTX N/A
  • SMTC N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • SMTC Semiconductors
  • Sector
  • VKTX Health Care
  • SMTC Technology
  • Exchange
  • VKTX Nasdaq
  • SMTC Nasdaq
  • Market Cap
  • VKTX 3.8B
  • SMTC 4.3B
  • IPO Year
  • VKTX 2015
  • SMTC N/A
  • Fundamental
  • Price
  • VKTX $34.40
  • SMTC $64.52
  • Analyst Decision
  • VKTX Strong Buy
  • SMTC Strong Buy
  • Analyst Count
  • VKTX 14
  • SMTC 15
  • Target Price
  • VKTX $87.07
  • SMTC $64.87
  • AVG Volume (30 Days)
  • VKTX 4.3M
  • SMTC 1.6M
  • Earning Date
  • VKTX 10-22-2025
  • SMTC 11-24-2025
  • Dividend Yield
  • VKTX N/A
  • SMTC N/A
  • EPS Growth
  • VKTX N/A
  • SMTC N/A
  • EPS
  • VKTX N/A
  • SMTC 0.29
  • Revenue
  • VKTX N/A
  • SMTC $996,476,000.00
  • Revenue This Year
  • VKTX N/A
  • SMTC $15.91
  • Revenue Next Year
  • VKTX N/A
  • SMTC $9.77
  • P/E Ratio
  • VKTX N/A
  • SMTC $221.36
  • Revenue Growth
  • VKTX N/A
  • SMTC 22.22
  • 52 Week Low
  • VKTX $18.92
  • SMTC $24.05
  • 52 Week High
  • VKTX $56.25
  • SMTC $79.52
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 44.88
  • SMTC 44.49
  • Support Level
  • VKTX $34.67
  • SMTC $62.11
  • Resistance Level
  • VKTX $43.15
  • SMTC $69.43
  • Average True Range (ATR)
  • VKTX 2.70
  • SMTC 4.26
  • MACD
  • VKTX -0.69
  • SMTC -0.90
  • Stochastic Oscillator
  • VKTX 13.85
  • SMTC 24.37

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About SMTC Semtech Corporation

Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.

Share on Social Networks: